JUAN CARLOS
VALLEJO LLAMAS
Ikertzailea 2022-(e)ra arte
Pfizer (United States)
Nueva York, Estados UnidosPfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2017
-
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in spain
ClinicoEconomics and Outcomes Research, Vol. 9, pp. 39-47